1型糖尿病病程前5年内出现视网膜病变与后续晚期视网膜病变风险
研究评估1型糖尿病病程5年内出现早期视网膜病变(EDR)者后续发生晚期视网膜病变的风险:EDR组484例与无EDR组369例相比,未校正模型中增殖性糖尿病视网膜病变(PDR)、临床显著黄斑水肿(CSME)和糖尿病相关视网膜光凝风险升高;校正HbA1c后仍显著,进一步校正多项因素后仅PDR关联仍显著(HR 1.47)。
要点
- 1型糖尿病病程5年内出现任何视网膜病变征象者,后续晚期糖尿病视网膜病变风险可能更高,尤其是PDR。
- 未校正模型中EDR组PDR风险HR 1.51、CSME风险HR 1.44、视网膜光凝风险HR 1.48,均高于无EDR组。
- 多因素校正后仅PDR关联仍显著(HR 1.47,95%CI 1.04–2.06,P=0.028)。
核心结论
- 数据提示1型糖尿病发病后5年内出现任何视网膜病变征象者,长期发生晚期糖尿病视网膜病变的风险可能更高,尤其是PDR。
- 识别早发视网膜病变可能影响预后,并有助于指导治疗管理以降低未来视力丧失风险。
研究设计与样本
- 纵向研究,使用标准化立体眼底七视野摄影按6个月至4年的间隔评估糖尿病视网膜病变。
- 早发视网膜病变(EDR)定义为1型糖尿病病程5年前出现病变;EDR组484例,无EDR组369例。
- 采用Cox模型评估EDR与后续结局风险的关联。
主要发现
- 未校正模型中,EDR组(n=484)较无EDR组(n=369)后续PDR风险升高(HR 1.51,95%CI 1.12–2.02,P=0.006)。
- 未校正模型中,EDR组较无EDR组CSME风险升高(HR 1.44,95%CI 1.10–1.88,P=0.008)。
- 未校正模型中,EDR组较无EDR组糖尿病相关视网膜光凝风险升高(HR 1.48,95%CI 1.12–1.96,P=0.006)。
- 校正HbA1c后上述关联仍显著;进一步校正年龄、1型糖尿病病程、HbA1c、性别、收缩压/舒张压、脉搏、ACE抑制剂使用、白蛋白排泄率及估算肾小球滤过率后,仅PDR关联仍显著(HR 1.47,95%CI 1.04–2.06,P=0.028)。
临床怎么用
- 作者认为,识别早发视网膜病变可能影响预后,并有助于指导治疗管理以降低这些个体未来视力丧失的风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether individuals with type 1 diabetes (T1D) who develop any retinopathy at any time prior to 5 years of diabetes duration have an increased subsequent risk for further progression of retinopathy or onset of proliferative diabetic retinopathy (PDR), clinically significant macular edema (CSME), diabetes-related retinal photocoagulation, or anti-vascular endothelial growth factor injections. Additionally, to determine the influence of HbA1c and other risk factors in these individuals. RESEARCH DESIGN AND METHODS: Diabetic retinopathy (DR) was assessed longitudinally using standardized stereoscopic seven-field fundus photography at time intervals of 6 months to 4 years. Early-onset DR (EDR) was defined as onset prior to 5 years of T1D duration. Cox models assessed the associations of EDR with subsequent risk of outcomes. RESULTS: In unadjusted models, individuals with EDR (n = 484) had an increased subsequent risk of PDR (hazard ratio [HR] 1.51 [95% CI 1.12, 2.02], P = 0.006), CSME (HR 1.44 [1.10, 1.88], P = 0.008), and diabetes-related retinal photocoagulation (HR 1.48 [1.12, 1.96], P = 0.006) compared with individuals without EDR (n = 369). These associations remained significant when adjusted for HbA1c, but only the association with PDR remained significant after adjustment for age, duration of T1D, HbA1c, sex, systolic/diastolic blood pressure, pulse, use of ACE inhibitors, albumin excretion rate, and estimated glomerular filtration rate (HR 1.47 [95% CI 1.04, 2.06], P = 0.028). CONCLUSIONS: These data suggest that individuals with any sign of retinopathy within the first 5 years of T1D onset may be at higher risk of long-term development of advanced DR, especially PDR. Identification of early-onset DR may influence prognosis and help guide therapeutic management to reduce the risk of future visual loss in these individuals.
引用
- Malone JI, Gao X, Lorenzi GM, et al. Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced Retinopathy. Diabetes Care. 2023. PMID: 36511796. doi:10.2337/dc22-1711
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。